Clinical Trials Directory

Trials / Sponsors / Kodiak Sciences Inc

Kodiak Sciences Inc

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema
Macular Edema Secondary to Inflammation
Phase 32025-07-30
RecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema
Macular Edema Secondary to Inflammation
Phase 32025-07-16
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Afliber
Wet Age-related Macular Degeneration
Phase 32024-08-23
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participant
Diabetic Retinopathy
Phase 32024-05-01
TerminatedA Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy
Non-proliferative Diabetic Retinopathy
Phase 32021-09-07
CompletedA Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in
Wet Age-related Macular Degeneration
Phase 32021-06-23
TerminatedA Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants Wi
Diabetic Macular Edema
Phase 32020-09-30
TerminatedA Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants Wi
Diabetic Macular Edema
Phase 32020-09-30
CompletedA Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With M
Macular Edema, Retinal Vein Occlusion
Phase 32020-09-25
TerminatedA Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Afl
Wet Macular Degeneration
Phase 2 / Phase 32019-10-08
TerminatedExploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokineti
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema
Phase 12018-12-26